134 related articles for article (PubMed ID: 33810067)
1. Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli.
Miró-Canturri A; Ayerbe-Algaba R; Vila-Domínguez A; Jiménez-Mejías ME; Pachón J; Smani Y
Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33810067
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
[TBL] [Abstract][Full Text] [Related]
3. Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli.
Miró-Canturri A; Ayerbe-Algaba R; Del Toro R; Mejías ME; Pachón J; Smani Y
Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34073235
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of
Herrera-Espejo S; Vila-Domínguez A; Cebrero-Cangueiro T; Smani Y; Pachón J; Jiménez-Mejías ME; Pachón-Ibáñez ME
Antibiotics (Basel); 2024 Apr; 13(5):. PubMed ID: 38786115
[TBL] [Abstract][Full Text] [Related]
5. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial.
Giammanco A; Calà C; Fasciana T; Dowzicky MJ
mSphere; 2017; 2(1):. PubMed ID: 28124025
[TBL] [Abstract][Full Text] [Related]
6. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
7. Addition of L-cysteine to the N- or C-terminus of the all-D-enantiomer [
Ohno MK; Kirikae T; Yoshihara E; Kirikae F; Ishida I
PeerJ; 2020; 8():e10176. PubMed ID: 33335804
[TBL] [Abstract][Full Text] [Related]
8. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
Konai MM; Haldar J
ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
[TBL] [Abstract][Full Text] [Related]
9. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
10. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
12. The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.
Ayerbe-Algaba R; Gil-Marqués ML; Miró-Canturri A; Parra-Millán R; Pachón-Ibáñez ME; Jiménez-Mejías ME; Pachón J; Smani Y
Int J Antimicrob Agents; 2019 Oct; 54(4):507-512. PubMed ID: 31299296
[TBL] [Abstract][Full Text] [Related]
13. High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.
Titecat M; Liang X; Lee CJ; Charlet A; Hocquet D; Lambert T; Pagès JM; Courcol R; Sebbane F; Toone EJ; Zhou P; Lemaitre N
J Antimicrob Chemother; 2016 Oct; 71(10):2874-82. PubMed ID: 27330072
[TBL] [Abstract][Full Text] [Related]
14. Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria.
Domalaon R; Ammeter D; Brizuela M; Gorityala BK; Zhanel GG; Schweizer F
Front Microbiol; 2019; 10():1556. PubMed ID: 31354660
[TBL] [Abstract][Full Text] [Related]
15.
Pi H; Nguyen HT; Venter H; Boileau AR; Woolford L; Garg S; Page SW; Russell CC; Baker JR; McCluskey A; O'Donovan LA; Trott DJ; Ogunniyi AD
Front Microbiol; 2020; 11():1556. PubMed ID: 32849325
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activity of herbal volatile oil extracts against multidrug-resistant
Intorasoot A; Chornchoem P; Sookkhee S; Intorasoot S
J Intercult Ethnopharmacol; 2017; 6(2):218-222. PubMed ID: 28512603
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Biedenbach DJ; Giao PT; Hung Van P; Su Minh Tuyet N; Thi Thanh Nga T; Phuong DM; Vu Trung N; Badal RE
Clin Ther; 2016 Sep; 38(9):2098-105. PubMed ID: 27612610
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria.
Vila Domínguez A; Ayerbe Algaba R; Miró Canturri A; Rodríguez Villodres Á; Smani Y
Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31963769
[TBL] [Abstract][Full Text] [Related]
20. [Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli].
Paluchowska P; Skałkowska M; Spelak A; Budak A
Med Dosw Mikrobiol; 2012; 64(1):45-53. PubMed ID: 22808729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
